Seropositivity for cytomegalovirus and PCR-EBV monitoring: Protective factors for posttransplant lymphoproliferative disorder in pediatric liver transplant.
Lígia Patrícia de Carvalho Batista ÉboliAna Cristina Aoun TannuriXingzhi LiaoPublished in: Pediatric transplantation (2022)
Monitoring the EBV viral load by PCR seems to prevent the emergence of milder forms of lymphoproliferative disorder. Pretransplant seropositivity for CMV is a protective factor for PTLD.